Startup Vitasense today said it secured significant funding to advance its non-invasive wearable glucose monitoring technology.
Junior high innovator Max Kopp from Germantown Academy in Pennsylvania leads the diabetes management startup. Crown Wealth, with strategic collaboration from KB Global Holding and other top universities, provided the undisclosed funding. The company said its funding marks a major milestone in advancing its mission of transforming diabetes management and healthcare accessibility.
“Max Kopp and his team at Vitasense have demonstrated an extraordinary level of commitment and ingenuity in bringing this revolutionary technology to life. Their ability to navigate complex research, secure industry partnerships, and lead negotiations at such a young age is truly inspiring,” said a Crown Wealth spokesperson. “We believe in their vision and are proud to support them as they push forward in the development of this essential healthcare technology.”
According to a news release, the investment provides Vitasense with the necessary resources to refine its third-generation prototype. Funds should also help enhance regulatory compliance efforts and prepare for large-scale clinical testing. The company has worked with biomedical engineers and healthcare professionals to ensure efficacy and usability for diabetes patients.
Vitasense said it remains committed to ensuring a meaningful impact on millions of lives through its wearable glucose monitor.
The technology utilizes polarized light in a portable glucometer for daily monitoring. According to Vitasense, the technology offers enhanced accuracy, is AI-powered and delivers real-time data.
“Crown Wealth’s investment in Vitasense reflects our commitment to supporting innovative solutions that address pressing global health challenges,” the spokesperson said. “We see tremendous potential in this young, driven team and are excited to see how their work will contribute to the future of diabetes management.”
